\-\ Texto\\:\\ \ \(0\)\
\-\ bronchial\\ washings\\ \\-\\ no\\ malignant\\ cells\\,\\ no\\ eosinophilia\\,\\ no\\ organisms\\ isolated\ \(0\)\
\-\ steroids\\ as\\ above\ \(0\)\
\-\ several\\ axial\\ ct\\ images\\ demonstrate\\ patchy\\ bilateral\\ consolidations\\ along\\ the\\ bronchovascular\\ bundles\\ with\\ diffuse\\ ground\\ glass\\.\\ \ \(0\)\
\-\ conventional\\ chest\\ radiographs\\ show\\ improvement\\ in\\ the\\ disease\\ process\\ in\\ 48\\ hours\\ after\\ steroid\\ administration\\.\ \(0\)\
\-\ boop\\/cop\ \(0\)\
\-\ atypical\\ infectious\\ etiologies\\ to\\ include\\ fungal\\/tb\ \(0\)\
\-\ sarcoid\ \(163\)\
\-\ bronchoalveolar\\ carcinoma\ \(5\)\
\-\ eosinophilic\\ pneumonia\ \(5\)\
\-\ cryptogenic\\ organizing\\ pneumonia\\ \\(cop\\ \\-\\ previously\\ boop\\)\ \(0\)\
\-\ low\\ grade\\ fever\\ with\\ cough\ \(0\)\
\-\ histologic\\ diagnosis\\:\\(masson\\ cells\\ \\â\\€\\“granulation\\ tissue\\ plugs\\ in\\ the\\ bronchioles\\)\ \(0\)\
\-\ etiologies\\ include\\ drugs\\,\\ post\\ infectious\\,\\ toxic\\ inhalational\\,\\ cryptogenic\ \(0\)\
\-\ \\(40\\-60\\,\\ no\\ sex\\ predilection\\)\ \(1\)\
\-\ elevated\\ esr\\ \\(\\>60\\)\\ in\\ 30\\%\\ of\\ patients\ \(0\)\
\-\ clinically\\ \\â\\€\\“\\ cough\\ and\\ low\\ grade\\ fever\ \(0\)\
\-\ no\\ improvement\\ with\\ antibiotics\ \(0\)\
\-\ ct\\ findings\\:\ \(0\)\
\-\ patchy\\ consolidations\\ in\\ subpleural\\ or\\ peribronchial\\ distribution\\,\\ ground\\ glass\ \(0\)\
\-\ may\\ present\\ with\\ centrilobular\\ nodules\\,\\ adenopathy\\,\\ or\\ effusions\\ \\(approx\\ 30\\%\\)\ \(0\)\
\-\ reverse\\ halo\\ \\(ground\\ glass\\ surrounded\\ by\\ consolidation\\ \\â\\€\\“\\ 30\\%\\)\ \(0\)\
\-\ differential\\:\\ atypical\\ infections\\,\\ tb\\,\\ mai\\,\\ sarcoid\\,\\ bac\\,\\ eosinophilic\\ pneumonia\\,\\ lymphoma\ \(0\)\
\-\ relapses\\ are\\ common\\ after\\ cessation\\ of\\ steroid\\ therapy\\ and\\ the\\ consolidations\\ may\\ persist\\ despite\\ therapy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ consolidations\\:\\ 0\\.1075534404706328\ \(0\)\
\-\ cryptogenic\\:\\ 0\\.07392262749101101\ \(0\)\
\-\ glass\\:\\ 0\\.07379578228445682\ \(0\)\
\-\ ground\\:\\ 0\\.0702185755193013\ \(0\)\
\-\ pneumonia\\:\\ 0\\.05272111485415686\ \(0\)\
\-\ 30\\:\\ 0\\.04904610949932948\ \(0\)\
\-\ etiologies\\:\\ 0\\.04714408935383859\ \(0\)\
\-\ patchy\\:\\ 0\\.045586188252430236\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.045586188252430236\ \(0\)\
\-\ steroid\\:\\ 0\\.04489008289315749\ \(0\)\
\-\ boop\\/cop\\:\\ 0\\.043858300616748745\ \(0\)\
\-\ fungal\\/tb\\:\\ 0\\.043858300616748745\ \(0\)\
\-\ masson\\:\\ 0\\.043858300616748745\ \(0\)\
\-\ \\â\\€\\“granulation\\:\\ 0\\.043858300616748745\ \(0\)\
\-\ sarcoid\\:\\ 0\\.043628871891772975\ \(0\)\
\-\ mai\\:\\ 0\\.040409807181127126\ \(0\)\
\-\ improvement\\:\\ 0\\.03967367847427062\ \(0\)\
\-\ cop\\:\\ 0\\.038392567837305415\ \(0\)\
\-\ plugs\\:\\ 0\\.038392567837305415\ \(0\)\
\-\ inhalational\\:\\ 0\\.038392567837305415\ \(0\)\
\-\ relapses\\:\\ 0\\.038392567837305415\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.03826572263075122\ \(0\)\
\-\ washings\\:\\ 0\\.03696131374550551\ \(0\)\
\-\ boop\\:\\ 0\\.03696131374550551\ \(0\)\
\-\ bac\\:\\ 0\\.03696131374550551\ \(0\)\
\-\ atypical\\:\\ 0\\.03685105110059657\ \(0\)\
\-\ infectious\\:\\ 0\\.03655576982551083\ \(0\)\
\-\ bronchioles\\:\\ 0\\.034177155596573056\ \(0\)\
\-\ 40\\-60\\:\\ 0\\.034177155596573056\ \(0\)\
\-\ cells\\:\\ 0\\.03409399695671639\ \(0\)\
\-\ eosinophilia\\:\\ 0\\.03351282030988389\ \(0\)\
\-\ organizing\\:\\ 0\\.03292683505786208\ \(0\)\
\-\ cough\\:\\ 0\\.0325796505354037\ \(0\)\
\-\ grade\\:\\ 0\\.03238643575075592\ \(0\)\
\-\ bronchovascular\\:\\ 0\\.03192847338889616\ \(0\)\
\-\ centrilobular\\:\\ 0\\.03192847338889616\ \(0\)\
\-\ peribronchial\\:\\ 0\\.03149558096606218\ \(0\)\
\-\ reverse\\:\\ 0\\.03072866216095144\ \(0\)\
\-\ halo\\:\\ 0\\.03072866216095144\ \(0\)\
\-\ bronchoalveolar\\:\\ 0\\.030385414044100934\ \(0\)\
\-\ subpleural\\:\\ 0\\.030385414044100934\ \(0\)\
\-\ bundles\\:\\ 0\\.029762711840349662\ \(0\)\
\-\ sex\\:\\ 0\\.029762711840349662\ \(0\)\
\-\ \\%\\:\\ 0\\.029751060199194143\ \(0\)\
\-\ fever\\:\\ 0\\.028768782353750907\ \(0\)\
\-\ predilection\\:\\ 0\\.028047087530440558\ \(0\)\
\-\ approx\\:\\ 0\\.027648865104204057\ \(0\)\
\-\ persist\\:\\ 0\\.02746110227841875\ \(0\)\
\-\ histologic\\:\\ 0\\.026936920608479315\ \(0\)\
\-\ cessation\\:\\ 0\\.026773787161598766\ \(0\)\
\-\ organisms\\:\\ 0\\.02576085703602046\ \(0\)\
\-\ toxic\\:\\ 0\\.024919681264657604\ \(0\)\
\-\ surrounded\\:\\ 0\\.02429697906090633\ \(0\)\
\-\ bronchial\\:\\ 0\\.02410560452942476\ \(0\)\
\-\ conventional\\:\\ 0\\.02410560452942476\ \(0\)\
\-\ include\\:\\ 0\\.02385227351273917\ \(0\)\
\-\ low\\:\\ 0\\.02364346321260099\ \(0\)\
\-\ drugs\\:\\ 0\\.0234884271728577\ \(0\)\
\-\ therapy\\:\\ 0\\.02273274424120013\ \(0\)\
\-\ isolated\\:\\ 0\\.022119754087062075\ \(0\)\
\-\ effusions\\:\\ 0\\.02169736879459199\ \(0\)\
\-\ \\(\\:\\ 0\\.021563036604294344\ \(0\)\
\-\ esr\\:\\ 0\\.021526776389225663\ \(0\)\
\-\ no\\:\\ 0\\.021404083350840847\ \(0\)\
\-\ consolidation\\:\\ 0\\.021308054382155432\ \(0\)\
\-\ \\)\\:\\ 0\\.021299632600397165\ \(0\)\
\-\ 48\\:\\ 0\\.020799947441476927\ \(0\)\
\-\ tb\\:\\ 0\\.020472826160070057\ \(0\)\
\-\ infections\\:\\ 0\\.0202085981734335\ \(0\)\
\-\ \\,\\:\\ 0\\.020202243695319953\ \(0\)\
\-\ steroids\\:\\ 0\\.019998646161043566\ \(0\)\
\-\ despite\\:\\ 0\\.019757867350785607\ \(0\)\
\-\ distribution\\:\\ 0\\.01913286131537561\ \(0\)\
\-\ adenopathy\\:\\ 0\\.018929766815274838\ \(0\)\
\-\ may\\:\\ 0\\.018650033521374367\ \(0\)\
\-\ clinically\\:\\ 0\\.018639871749981426\ \(0\)\
\-\ 60\\:\\ 0\\.0185468760633538\ \(0\)\
\-\ \\-\\:\\ 0\\.018226153817993668\ \(0\)\
\-\ previously\\:\\ 0\\.017859560946533817\ \(0\)\
\-\ administration\\:\\ 0\\.01765005106917\ \(0\)\
\-\ nodules\\:\\ 0\\.017624471967177868\ \(0\)\
\-\ after\\:\\ 0\\.017592051767255746\ \(0\)\
\-\ \\:\\:\\ 0\\.016869773372995\ \(0\)\
\-\ hours\\:\\ 0\\.016717399545317396\ \(0\)\
\-\ process\\:\\ 0\\.016368484999177684\ \(0\)\
\-\ antibiotics\\:\\ 0\\.01596873809786319\ \(0\)\
\-\ above\\:\\ 0\\.01558178436133242\ \(0\)\
\-\ malignant\\:\\ 0\\.015366520778006473\ \(0\)\
\-\ elevated\\:\\ 0\\.014424459509249069\ \(0\)\
\-\ \\>\\:\\ 0\\.014125211515764001\ \(0\)\
\-\ along\\:\\ 0\\.014050019287853314\ \(0\)\
\-\ several\\:\\ 0\\.013667128535932277\ \(0\)\
\-\ differential\\:\\ 0\\.01349731258384542\ \(0\)\
\-\ radiographs\\:\\ 0\\.013464034035831506\ \(0\)\
\-\ post\\:\\ 0\\.013387238970508924\ \(0\)\
\-\ show\\:\\ 0\\.01305052703727177\ \(0\)\
\-\ diffuse\\:\\ 0\\.012870683683459278\ \(0\)\
\-\ lymphoma\\:\\ 0\\.012150241962136744\ \(0\)\
\-\ axial\\:\\ 0\\.012133290925710803\ \(0\)\
\-\ carcinoma\\:\\ 0\\.012049391393113763\ \(0\)\
\-\ ct\\:\\ 0\\.01189356869046809\ \(0\)\
\-\ common\\:\\ 0\\.01112570752217113\ \(0\)\
\-\ patients\\:\\ 0\\.011002858703313561\ \(0\)\
\-\ in\\:\\ 0\\.01048251816269291\ \(0\)\
\-\ bilateral\\:\\ 0\\.01031750114086788\ \(0\)\
\-\ chest\\:\\ 0\\.010172781094813526\ \(0\)\
\-\ tissue\\:\\ 0\\.01007672233060992\ \(0\)\
\-\ or\\:\\ 0\\.00996540048720107\ \(0\)\
\-\ demonstrate\\:\\ 0\\.009783343986731545\ \(0\)\
\-\ diagnosis\\:\\ 0\\.009762285227763283\ \(0\)\
\-\ present\\:\\ 0\\.009602033601650153\ \(0\)\
\-\ findings\\:\\ 0\\.009048939979054526\ \(0\)\
\-\ images\\:\\ 0\\.008155541750991811\ \(0\)\
\-\ by\\:\\ 0\\.007078959717636193\ \(0\)\
\-\ disease\\:\\ 0\\.0069489429911229065\ \(0\)\
\-\ as\\:\\ 0\\.00643073386016979\ \(0\)\
\-\ are\\:\\ 0\\.005795392400644785\ \(0\)\
\-\ the\\:\\ 0\\.002751229546340812\ \(0\)\
\-\ with\\:\\ 0\\.002328441315221686\ \(0\)\
\-\ to\\:\\ 0\\.0021247169574277924\ \(0\)\
\-\ and\\:\\ 0\\.0017911343853952084\ \(0\)\
\-\ of\\:\\ 0\\.0011592417989849594\ \(0\)\
\-\ \\.\\:\\ 0\\.0005298438223484518\ \(0\)\
